Rifaximin Dosing for Hepatic Encephalopathy in Cirrhosis with Ascites

Standard Dosing Regimen

The recommended dose is rifaximin 550 mg orally twice daily, which is the FDA-approved and guideline-supported regimen for preventing recurrence of overt hepatic encephalopathy in patients with cirrhosis 1
An alternative dosing option is rifaximin 400 mg three times daily (total 1,200 mg/day), though the twice-daily regimen is more commonly used and better studied 1
The maximum recommended dose is 1,200 mg/day 1

Rifaximin should be prescribed in combination with lactulose for optimal management of hepatic encephalopathy, as this combination demonstrates superior outcomes compared to either agent alone 1
Patients treated with rifaximin plus lactulose showed better recovery from hepatic encephalopathy within 10 days (76% vs. 44%, p=0.004) and shorter hospital stays (5.8 vs. 8.2 days, p=0.001) compared to lactulose alone 1
Lactulose dosing should be 20-30 g (30-45 mL) orally 3-4 times daily, titrated to achieve 2-3 soft stools per day 1

Rifaximin has limitations in severe hepatic encephalopathy (West-Haven grade 3 or higher) because it requires oral administration 1
For patients unable to take oral medications, consider nasogastric tube administration or lactulose enemas (300 mL lactulose mixed with 700 mL water, 3-4 times daily) until oral intake is possible 1, 2
Once the patient can take oral medications, transition to rifaximin 550 mg twice daily 1

Rifaximin is not absorbed systemically, maintaining high intestinal concentrations where it exerts its antimicrobial effects against ammonia-producing bacteria 1